HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ipilimumab and Imatinib Mesylate in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Peptide Vaccinations Plus GM-CT-01 in Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
- Status
- COMPLETED
- Phase
- NA
Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE4
Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Of 18F MEL050 Using PET/CT in Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Aerosolized Aldesleukin in Treating Patients With Lung Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Circulating Tumor Cells and Melanoma: Comparing the EPISPOT and CellSearch Techniques
- Status
- COMPLETED
- Phase
- N/A
Metronomic Therapy in Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma
- Status
- UNKNOWN
- Phase
- NA